Celebrating our Journey of Hope! Join us as we usher in PWSA | USA’s 50th Anniversary. Learn More

Advocacy & Awareness

Advocacy Events & Calls to Action

Voice of the Patient Report

On May 1, 2024, the beginning of PWS Awareness Month, we announced the release of the Voice of the Patient Report. This timely filing marks a significant moment for the Prader-Willi syndrome community! The report gives crucial insights that amplify the perspective of individuals and families affected by PWS and sheds light on aspects of PWS that may not be fully captured in drug trials alone. Integrating the patient’s voice throughout the drug approval process for PWS treatments is essential for the U.S. Food and Drug Administration’s (FDA) comprehensive understanding and impactful decision-making. 

The Voice of the Patient Report was created following the June 2023 PWS Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting and is compiled of testimonials shared during the EL-PFDD meeting, as well as those submitted virtually.

PWSA | USA, FPWR, and IPWSO extend heartfelt gratitude to the entire PWS community for contributing to the success of this project. To truly amplify the patient’s voice, our entire community must commit to ongoing advocacy efforts. This entails incorporating patient perspectives into all facets of processes and systems, ensuring genuine and enduring change. It’s not solely about isolated advocacy initiatives—it’s about steadfast dedication to embracing and elevating the voices of those directly affected by Prader-Willi syndrome.

You can read the Voice of the Patient Report by clicking the button below.

Find your Representative

PWS State Qualifier Campaign

We are excited to share that several new community members are in the beginning stages of having PWS added to their state’s list of developmental disabilities.

PWS State Qualifier Campaign Map

If you or someone you know is interested in leading the charge in your state, please email PWSA | USA at Advocacy@pwsausa.org.

Meet some of PWSA | USA’s advocates

PWSA | USA's Advocacy in Action Webinar

Check Out PWSA | USA'S
PWS Awareness Month Hub

A Big Step Forward
EL-PFDD Meeting

Your voice made a difference! PWS’s First Externally Led Patient-Focused Drug Development Meeting was a success. We have officially filed the Voice of the Patient Report, which is a document put together to include the stories shared during the meeting and submitted virtually. Click the button below to find the report and to learn more about the EL-PFDD.

VISIT OUR BLOG

Changes at FDA’s Center for Drug Evaluation and Research

Changes at FDA’s Center for Drug Evaluation and Research

The Prader-Willi Syndrome Association | USA (PWSA | USA) and the Foundation for Prader-Willi Research (FPWR) would like to take a moment to acknowledge a significant leadership transition at the U.S. Food and Drug Administration (FDA). As Dr. Patrizia Cavazzoni steps down as Director of the Center for Drug Evaluation and Research (CDER), we express […]

PWS Advocacy Master Class: Register Before January 13th!

PWS Advocacy Master Class: Register Before January 13th!

Launching on January 13, 2025, the PWS Advocacy Master Class is a six-week program designed in collaboration with Patients Rising. It provides a robust curriculum for anyone passionate about becoming an effective advocate for PWS. Course Highlights: – Congress 101: A deep dive into how laws are made and how to engage with policymakers. – Pharmacy […]

Advocating for Rare Diseases: Year-End Highlights and Uncertain Next Steps

Advocating for Rare Diseases: Year-End Highlights and Uncertain Next Steps

Dorothea Lantz, PWSA | USA Community Engagement Director, and Elaine Towle, PWSA | USA volunteer advocate, recently represented the rare disease community in critical meetings on Capitol Hill with Sen. Shaheen, Sen. Hassan, Sen. Rubio, and Sen. Braun. These discussions emphasized advancing legislative priorities for 2025, including rare disease drug development, improving Medicaid access for […]

Scroll to top